AR118704A2 - FACTOR VII POLIPEPTIDE TO TREAT DISEASES - Google Patents
FACTOR VII POLIPEPTIDE TO TREAT DISEASESInfo
- Publication number
- AR118704A2 AR118704A2 ARP200101073A ARP200101073A AR118704A2 AR 118704 A2 AR118704 A2 AR 118704A2 AR P200101073 A ARP200101073 A AR P200101073A AR P200101073 A ARP200101073 A AR P200101073A AR 118704 A2 AR118704 A2 AR 118704A2
- Authority
- AR
- Argentina
- Prior art keywords
- polipeptide
- factor vii
- treat diseases
- diseases
- treat
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 229940012413 factor vii Drugs 0.000 title abstract 2
- 102100023804 Coagulation factor VII Human genes 0.000 abstract 1
- 108010023321 Factor VII Proteins 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Se describe un polipéptido del Factor VII aislado para tratar una enfermedad.A Factor VII polypeptide isolated for treating disease is described.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261745674P | 2012-12-24 | 2012-12-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR118704A2 true AR118704A2 (en) | 2021-10-27 |
Family
ID=56117356
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130105071A AR094317A1 (en) | 2012-12-24 | 2013-12-27 | SHORT ACTION FACTOR VII POLIPEPTIDES |
| ARP200101072A AR118703A2 (en) | 2012-12-24 | 2020-04-16 | FACTOR VII POLIPEPTIDE TO TREAT A DISEASE |
| ARP200101073A AR118704A2 (en) | 2012-12-24 | 2020-04-16 | FACTOR VII POLIPEPTIDE TO TREAT DISEASES |
| ARP200101074A AR118705A2 (en) | 2012-12-24 | 2020-04-16 | FACTOR VII POLIPEPTIDE TO TREAT DISEASES, METHOD FOR PREPARING IT AND COMPOSITION CONTAINING IT |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130105071A AR094317A1 (en) | 2012-12-24 | 2013-12-27 | SHORT ACTION FACTOR VII POLIPEPTIDES |
| ARP200101072A AR118703A2 (en) | 2012-12-24 | 2020-04-16 | FACTOR VII POLIPEPTIDE TO TREAT A DISEASE |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP200101074A AR118705A2 (en) | 2012-12-24 | 2020-04-16 | FACTOR VII POLIPEPTIDE TO TREAT DISEASES, METHOD FOR PREPARING IT AND COMPOSITION CONTAINING IT |
Country Status (1)
| Country | Link |
|---|---|
| AR (4) | AR094317A1 (en) |
-
2013
- 2013-12-27 AR ARP130105071A patent/AR094317A1/en active IP Right Grant
-
2020
- 2020-04-16 AR ARP200101072A patent/AR118703A2/en unknown
- 2020-04-16 AR ARP200101073A patent/AR118704A2/en unknown
- 2020-04-16 AR ARP200101074A patent/AR118705A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR094317A1 (en) | 2015-07-29 |
| AR118705A2 (en) | 2021-10-27 |
| AR118703A2 (en) | 2021-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC2785706I2 (en) | SUBSTITUTED 4-PHENYL-PYRIDINES FOR THE TREATMENT OF NK-RECEPTOR-RELATED DISEASES | |
| UY33627A (en) | COMPOUNDS TO TREAT NEURODEGENERATIVE DISEASES | |
| CR20130517A (en) | COMBINED TREATMENTS FOR MALIGNAS HEMATOLOGICAL NEOPLASIAS | |
| EA201891833A1 (en) | COMBINATION FOR THE TREATMENT OF AMIOTROPHIC SIDE SCLEROSIS OR RELATED DISEASES | |
| ES2765949T8 (en) | Therapy involving antibodies to claudin 18.2 for cancer treatment | |
| UY34782A (en) | HUMAN ANTIBODIES FOR FEL D1 AND METHODS TO USE THEM. | |
| EA201500314A1 (en) | DOSAGE FORMS OF ENZALUTAMIDE | |
| ECSP14013153A (en) | METALOENZYM INHIBITING COMPOUNDS | |
| BR112013024211A2 (en) | solid tumor treatment | |
| EA201490944A1 (en) | DOUBLE MET AND VEGF INHIBITOR FOR CANCER TREATMENT | |
| BR112013023241A2 (en) | improvements to fixed biological entities | |
| EA201400178A1 (en) | BREAST CANCER TREATMENT | |
| BR112013028512A2 (en) | capsule | |
| UY34885A (en) | ANTI-MESOTHELINE UNION PROTEINS | |
| CO6791570A2 (en) | New strain of European prrsv | |
| GT201400101A (en) | PREPARATION PROCEDURE FOR REPLACED 5-FLUORO-1H-PIRAZOLOPIRIDINAS | |
| EP2906208A4 (en) | THERAPEUTIC TREATMENT | |
| HUE042239T2 (en) | Tamoxifen derivatives are used to treat neoplastic diseases, especially at higher levels of HER2 protein | |
| BR112013028187A2 (en) | process to produce olefins | |
| ES2859604T8 (en) | LY75 Conjugated Antibodies for Cancer Treatment | |
| MX2015003701A (en) | COMPOSITIONS FOR TREATMENT. | |
| EP2830633A4 (en) | COMBINED THERAPY FOR THE TREATMENT OF CANCER | |
| MX357656B (en) | Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases. | |
| EP2831110A4 (en) | ANTI-EMP2 TREATMENT REDUCING CANCER STEM CELLS | |
| BR112013023144A2 (en) | scalp treatment method |